VALERIE SCHOFIELD: Open Payments
NPI 1871968206 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$934 in 57 payments from 12 companies in 2025. Trend: 2023 $20 · 2024 $274 · 2025 $934
Food & beverage: $934
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 14 | $225 |
| ABBVIE INC. | 18 | $211 |
| Lundbeck LLC | 8 | $143 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $91 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| Janssen Pharmaceuticals, Inc | 2 | $47 |
| Corium, LLC | 2 | $41 |
| Collegium Pharmaceutical, Inc. | 2 | $35 |
| Almatica Pharma LLC | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
Products named: REXULTI, VRAYLAR, CAPLYTA, Auvelity, SPRAVATO, Azstarys, Jornay PM, LOREEV XR.
Industry payments across AL — which companies pay providers there.
